Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory studyFrancesco Schettini, Tiziana Triulzi, Alfredo Molteni et al.|Breast Cancer Research and Treatment|2020Cited by 20
Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity TrialFrancesco Schettini, Daniele Generali, Silvia Paola Corona et al.|Frontiers in Oncology|2021Cited by 19